Literature DB >> 22847238

Thyroid cancer: Pazopanib alone is not effective against anaplastic thyroid cancer.

Andy McLarnon.   

Abstract

Entities:  

Year:  2012        PMID： 22847238     DOI： 10.1038/nrendo.2012.136

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Authors:  Keith C Bible; Vera J Suman; Michael E Menefee; Robert C Smallridge; Julian R Molina; William J Maples; Nina J Karlin; Anne M Traynor; Priya Kumar; Boon Cher Goh; Wan-Teck Lim; Ayoko R Bossou; Crescent R Isham; Kevin P Webster; Andrea K Kukla; Carolyn Bieber; Jill K Burton; Pamela Harris; Charles Erlichman
Journal:  J Clin Endocrinol Metab       Date:  2012-07-06       Impact factor: 5.958
  1 in total
  7 in total

Review 1.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

2.  Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.

Authors:  Paul Weinberger; Sithara Raju Ponny; Hongyan Xu; Shan Bai; Robert Smallridge; John Copland; Ashok Sharma
Journal:  Thyroid       Date:  2016-12-15       Impact factor: 6.568

3.  Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer.

Authors:  Teresa Di Desidero; Alessandro Antonelli; Paola Orlandi; Silvia Martina Ferrari; Anna Fioravanti; Greta Alì; Gabriella Fontanini; Fulvio Basolo; Giulio Francia; Guido Bocci
Journal:  Cancer Lett       Date:  2017-09-28       Impact factor: 8.679

4.  Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases.

Authors:  Tian-Run Liu; Zhi-Wen Xiao; Hai-Neng Xu; Zhen Long; Fan-Qin Wei; Shi-Min Zhuang; Xiao-Mei Sun; Liang-En Xie; Jia-Sheng Mu; An-Kui Yang; Guan-Ping Zhang; Yi Fan
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

5.  Treatment outcomes of radiotherapy for anaplastic thyroid cancer.

Authors:  Jong Won Park; Seo Hee Choi; Hong In Yoon; Jeongshim Lee; Tae Hyung Kim; Jun Won Kim; Ik Jae Lee
Journal:  Radiat Oncol J       Date:  2018-06-29

6.  Transition from childhood to adulthood in coeliac disease: the Prague consensus report.

Authors:  Jonas F Ludvigsson; Lars Agreus; Carolina Ciacci; Sheila E Crowe; Marilyn G Geller; Peter H R Green; Ivor Hill; A Pali Hungin; Sibylle Koletzko; Tunde Koltai; Knut E A Lundin; M Luisa Mearin; Joseph A Murray; Norelle Reilly; Marjorie M Walker; David S Sanders; Raanan Shamir; Riccardo Troncone; Steffen Husby
Journal:  Gut       Date:  2016-04-18       Impact factor: 23.059

7.  Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells.

Authors:  Teresa Di Desidero; Paola Orlandi; Daniela Gentile; Guido Bocci
Journal:  Front Oncol       Date:  2019-11-12       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.